Cloperastine Hydrochloride → (2S,4R)-1-BOC-2-hydroxyMethyl-4-aMino Pyrrolidine-HCl

HRID 1692380

반응식

HRID 1692380 반응식
C[O:2][C:3]([C@@H:5]1[CH2:9][C@@H:8]([N:10]=[N+]=[N-])[CH2:7][N:6]1[C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14])=O.C1CCN(CCOC(C2C=CC(Cl)=CC=2)C2C=CC=CC=2)CC1.Cl.[H-].[H-].[H-].[H-].[Li+].[Al+3]>C1COCC1>[C:16]([O:15][C:13]([N:6]1[CH2:7][C@H:8]([NH2:10])[CH2:9][C@H:5]1[CH2:3][OH:2])=[O:14])([CH3:19])([CH3:18])[CH3:17]

참가 물질

5

실험 절차

A solution of (2S,4R)-4-azido-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester [Marusawa, H.; Setoi, H.; Sawada, A.; Kuroda, A.; Seki, J.; Motoyama, Y.; Tanaka, H. Bioorganic & Medicinal Chemistry (2002), 10(5), 1399-1415] (1.0 g, 4 mmol) in THF (5 ml) was added to an ice-cooled suspension of LAH (0.6 g, 15 mmol) in THF (5 ml) under Ar. The reaction was stirred for 1 h after which time it was quenched by cautious addition of water. The resulting precipitate was filtered, rinsed with EtOAc and the organics concentrated. The crude (2S,4R)-4-amino-2-hydroxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (0.7 g, 3 mmol) thus obtained was then dissolved in CH2Cl2 (15 ml), saturated NaHCO3 (15 ml) was added followed by acetic anhydride (0.3 ml, 3 mmol) and the mixture stirred for 2 h. The reaction mixture was then separated, the organic phase dried (Na2SO4) and concentrated affording crude (2S,4R)-4-acetylamino-2-hydroxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (0.62 g, 79%). Treatment of this with a 4 N solution of hydrochloric acid in dioxane afforded the title product (0.5 g, quant) as a yellow powder. MS: 159.1 (MH+).

후처리

  1. temperaturecooled
  2. customwas quenched by cautious addition of water
  3. filtrationThe resulting precipitate was filtered
  4. washrinsed with EtOAc

출처 및 근거

ORD 기록
ord-dd35224282894a4195af3a5f320f7940
출처 데이터셋
uspto-grants-2012_04
특허 번호
US08153805B2

연결된 노트

불러오는 중…